<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Jimenez | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/townfish6/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/townfish6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Jimenez.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">19be208daca5e96e1e364aeab81d1957</guid>
				<title>Jimenez posted an update: PTSD symptoms of participants in the experimental group are [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38056/</link>
				<pubDate>Tue, 04 Feb 2025 09:09:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>PTSD symptoms of participants in the experimental group are expected to improve significantly more than those of participants in the waitlist control group (P=.05) with a large effect size (η</p>
<p> =0.14).</p>
<p> This is the first study to assess the relationship between e-CBT and ketamine and their combined ability to treat refractory PTSD. If&hellip;<span class="activity-read-more" id="activity-read-more-38056"><a href="http://www.nationalboardinstitute.com/activity/p/38056/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e6eddbdbc259cb97f00284e429c865a8</guid>
				<title>Jimenez posted an update: Silymarin is a purified mixture of four isomeric flavonoids [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33625/</link>
				<pubDate>Thu, 30 Jan 2025 09:58:31 -0800</pubDate>

									<content:encoded><![CDATA[<p>Silymarin is a purified mixture of four isomeric flavonoids extracted from the seeds and fruit of the milk thistle plant, Silybum marianus (L.). Silymarin exhibits a wide variety of biological effects and is commonly used in traditional medicine. Therefore, the anticancer effects of silymarin on human breast cancer cells were investigated to&hellip;<span class="activity-read-more" id="activity-read-more-33625"><a href="http://www.nationalboardinstitute.com/activity/p/33625/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50f53b213714e148a2ca6e395147cf39</guid>
				<title>Jimenez posted an update: RNA epigenetic modification take part in many biology [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29725/</link>
				<pubDate>Tue, 28 Jan 2025 13:57:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>RNA epigenetic modification take part in many biology processes, and the N6-methyladenosine (m6A) methylation of specific mRNAs in endometrial cancer (EC) tissues play a key role in regulating the tumorigenicity of EC, but the specific mechanism still unknown and need to be investigated in the future. Here, we found that m6A reader protein YTHDF2&hellip;<span class="activity-read-more" id="activity-read-more-29725"><a href="http://www.nationalboardinstitute.com/activity/p/29725/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">02b7c6382a9a18bd3632af7e648b9ed3</guid>
				<title>Jimenez became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29704/</link>
				<pubDate>Tue, 28 Jan 2025 13:55:37 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>